The simulation provided an opportunity for meeting attendees to observe the process by which oncologists determine initial diagnostic tests critical to treatment selection, the most appropriate treatment for each line of therapy, and criteria for subsequent treatment selection.
From The Field
Establishment of Subspecialized Care in Hematologic Malignancies and a Hematopoietic Cell Transplant Program
The Levine Cancer Institute of the Carolinas HealthCare System has had a large impact on hematopoietic cell transplant outcomes.
A Novel Case Management System to Address Patient-Identified Concerns in Hematology and Oncology Clinical Pathways
Researchers report on a novel patient-reported outcomes quality-of-life tool incorporated into a clinical pathway to see if patient well-being could be improved.
The authors used an indirect approach to deriving health state utilities for patients with MBC by mapping HRQOL data using a published regression algorithm
A mock clinical pathway development simulation was conducted to make transparent the process of developing consensus-driven, evidence-based clinical pathways in oncology.
Development and Implementation of De Novo Clinical Decision Support Rules at a Tertiary Cancer Center
The authors detail the development of a set of decision support rules for application within a major academic medical center and across its affiliated community satellite sites.
The authors discuss tactics for ensuring appropriate compliance with clinical pathways among health care providers in large-scale health networks.